The Preeclampsia Foundation announced today the recipients of its 2025 Peter Joseph Pappas Research Grants. Based on the recommendations of its Scientific Advisory Council, the Preeclampsia Foundation ...

2 Department of Community Medicine, NSCB Medical College, Jabalpur, India. Objective: To determine the incidence of HELLP syndrome amongst cases of Eclampsia and severe pre eclampsia admitted to our ...

Patients with T2D are at higher risk for adverse pregnancy outcomes like preeclampsia, preterm birth, and neonatal complications. GLP-1 receptor agonists such as semaglutide, which are effective drugs ...

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

Background: The HELLP syndrome is a serious complication ... 0.5 to 0.9% of all pregnancies and in 10-20% of cases with severe preeclampsia. The present review highlights occurrence, diagnosis ...

Preeclampsia is a life-threatening condition ... As its name implies, HELLP causes elevated liver enzymes and a low blood platelet count, which can be life-threatening occurrences for both ...

We included participants who self-reported a history of at least one pregnancy complicated by the HDP of: pre-eclampsia, haemolysis, elevated liver enzymes, low platelets syndrome (HELLP syndrome), ...

Preeclampsia in pregnancy is a condition characterized by high blood pressure and high protein in the urine during pregnancy or right after delivery. It usually develops after 20 weeks of pregnancy.

Purpose: Pharmacotherapeutic options for the treatment of preeclampsia are reviewed. Summary: Risk factors for the development of preeclampsia include microvascular diseases, such as diabetes ...